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1 Introduction
Fisheries are generally industries that generate high 
amounts of wastes (skin, viscera, heads, bones, contaminated 
water, etc.). When not properly disposed, these kinds of wastes 
may have great impacts on the environment. By means of food 
technology, production of fish flour, protein hydrolyzates, enzyme 
concentrates, chitosan elaboration, etc., have constituted strategies 
for the use of these wastes, reducing their negative impacts on 
diverse ecosystems and, at the same time, providing them of a 
added-value to fisheries by-products. However, another alternative 
for the utilization of fisheries wastes is the search and isolation 
of bioactive or functional compounds.
Marine animals and plants, inhabiting a wide range 
of ecosystems some of them still unexplored, synthetize a 
number of compounds that have been found to have biological 
activities that are of great interest for industries such as food 
processing and biomedicine, among other (Suleria et al., 2016; 
Pereira et al., 2016; Zhang et al., 2016). Much of the research 
in this area has been focused on marine lipidic compounds 
found in seafood such as unsaturated fatty acids ω-3 and ω-6, to 
which prevention of chronico-degenerative illnesses have been 
attributed (Burgos-Hernández et al., 2001; Farzaneh-Far et al., 
2010; Shahidi & Miraliakbari, 2004; Ewaschuk  et  al., 2012; 
Chen et al., 2015; Darghosian et al., 2015; Leslie et al., 2015; 
Eide et al., 2016). However, little attention has been given to the 
chemical composition of seafood wastes (skin, viscera, and fish 
heads) as a source of biologically active molecules.
Based on the above, the aim of the present study was to 
detect and initiate the isolation of biologically active compounds 
from cantabrian anchovy (Engraulis encrarischolus) viscera 
that might be of potential interest for the biomedical and food 
processing industries.
2 Materials and methods
2.1 Testing species
Anchovy (Engraulis encrarischolus), captured in the Cantabrian 
Sea, was gutted and head and viscera were vacuum-packed, 
frozen, and transported to the Departamento de Tecnología 
Agroalimentaria, Universidad Miguel Hernández at Drihuela, 
Spain, where they were stored at –20 °C until used.
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ALF showed antifungal activity, BF and ACF showed the highest antioxidant potential, and HF and BF were antibacterial 
against several strains. Anchovy gut, which to the present study had not been reported for any bioactivity, has antimutagenic, 
antifungal, antioxidant, and antibacterial compounds, which need to be isolated for full characterization and study.
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2.2 Fractionation of anchovy viscera
Methanolic extract
Anchovy viscera were defrost, homogenized with a food 
processor, and lyophilized. Lyophilized anchovy viscera was 
combined with 6 parts (w/v) of methanol and agitated with a 
magnetic stirrer during 1 h. The resulting mixture was filtered 
through a Whatman No. 1 filter paper and the methanol was 
evaporated using a rotaevaporator under negative pressure. 
The methanolic extract (ME) was stored at –20 °C until further 
fractionation.
Methanolic extract fractionation
In order to separate bioactive compounds, a serial 
solvent-partitioning procedure was carried out using hexane, 
ethyl acetate, and butanol. In a 1000 mL beaker the ME was 
combined with 300 mL of each, ultra-pure water and hexane, 
and this mixture was agitated with a magnetic stirrer for 1 h. 
The resulting mixture was transferred into a 1000 mL separation 
funnel and the immiscible phases were allowed to separate for 
24 h. The aqueous phase was recovered in a graduated tube 
and placed in a beaker for further fractionation. The hexane 
phase was recovered in a distillation flask and the hexane was 
separated using a rotoevaporator under negative pressure in 
order to obtain the hexane-soluble fraction (HF).
The aqueous phase was combined with an identical volume 
of ethyl acetate and the procedure previously described for 
hexane was repeated in order to obtain the ethyl acetate soluble 
fraction (EAF). This same procedure was carried out with butanol 
in order to obtain the butanol-soluble fraction (BF). Finally, 
the aqueous phase resulting from this last step was evaporated 
stirring the solution under a fumes-extraction hood at 40 °C 
and the resulting dried materials were considered the aqueous 
fraction (AF).
2.3 Antimutagenic activity
Bacterial cultures
Salmonella typhimurium TA98 and TA100 tester strains 
were used. Fresh overnight tester axenic cultures were stored at 
–80 °C and routinely checked to confirm genetic characteristics 
using the procedure described by Maron & Ames (1983).
Antimutagenicity test
The Ames test was used to test the antimutagenic activity 
of anchovy viscera fractions. Fractions were reconstituted with 
dimethyl sulfoxide (DMSD) to a final concentration of 10 mg/mL, 
serially diluted (1:10 v/v) also with DMSD and spiked with pure 
aflatoxin AFB1 (AFB1) (Sigma-Aldrich, St. Louis, MD, U.S.) to a 
final concentration of 500 ng of AFB1/100 μL of diluted extract. 
Metabolic activation system S9 mix (Aroclor 1254-induced, 
Sprague-Dawley male rat liver in 0.154 M KCl solution, 
Molecular Toxicology, Inc.; Annapolis, MD, U.S.) was used to 
bioactivate AFB1. Residual mutagenicity of AFB1 was assayed 
using the standard plate incorporation procedure described by 
Maron & Ames (1983). Different AFB1 concentrations, including 
500 ng AFB1/100 μL, were used as controls for both tester strains. 
All assays were performed in triplicate.
2.4 Antioxidant activity
DPPH, ABTS, and FRAP assays
The free radical-scavenging activity, exerted by the fractions 
obtained from anchovy viscera, was evaluated using the DPPH, 
ABTS, and FRAP methods. DPPH method, based on the 
DPPH (2,2-diphenyl-1-picrylhydrazyl) radical and reported 
by Brand-Williams  et  al. (1995), was carried out combining 
10 µL of each fraction with 40 µL methanol, and 950 µL DPPH 
radical solution. This mixture was agitated and placed in the 
dark for 10 min. The absorbance at 515 nm was measured in a 
UV-Vis Uvikon XS spectrophotometer (Bio-Tek Instruments, 
Saint Quentin Yvelines, France).
ABTS [2,2-azinobis-(3-ethylbenzotiazoline-6-sulfonic acid)] 
radical based- and Fe+3 reducing antioxidant power (FRAP) 
methods, were carried out according to Re et al. (1999) and Benzie 
& Strain (1996), respectively. Briefly, 10 µL of sample (anchovy 
fractions) were combined with 900 µL of either an ABTS radical 
or FRAP reagent solution. The absorbance (at 734 and 593 nm 
for ABTS and FRAP, respectively) was measured after 10 min 
of reaction. In order to determine the antioxidant potential of 
the fractions, a 0.01-5.0 mM Trolox curve was prepared. All the 
analyses were carried out in triplicate with 2 independent 
repetitions.
2.5 Antifungal activity
Spore suspension
Sterile potato dextrose agar (PDA) contained in an Erlenmeyer 
flask was inoculated with an activated Alternaria alternata 
strain and incubated at darkness at 25 °C until sporulation. 
Upon sporulation, cultures were amended with 20 mL of a 0.1% 
Tween 80 solution whose spore concentration was determined 
with a Neubauer chamber. Resulted spore suspension was stored 
at 4 °C until used.
Radial growth inhibition assay
PDA Petri plates, amended with 2 mg/mL of anchovy gut 
fractions were inoculated with a 1 x 104 spore/mL suspension 
of Alternaria alternata culture, placing 30 μL of this suspension 
in the center of the plate. Three controls were used in this assay, 
plates containing only PDA, other containing PDA + methanol, 
and another one containing PDA amended with 2 mg/mL of 
Armetil® (8% metaloxyl + 64% mancozeb) as a positive control 
of fungal growth inhibition. Inoculated plates were incubated at 
25 °C in the dark and fungal radial growth was daily measured 
with a rule during a week. This assay was performed in triplicate.
2.6 Antibacterial activity
Microbial test
Six bacterial strains were tested in this research, including 
three Gram-negative bacteria (Escherichia coli CCM 3988, 
Shigella sonei CCM 1373 and Salmonella enterica subs. enterica 
CCM 3807), three Gram-positive bacteria (Bacillus subtilis 
sub. spizizenii CCM 1999, Enterococcus faecalis CCM 4224, 
Staphylococcus aureus subs. aureus CCM 2461). All tested strains 
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were collected from the Czech Collection of Microorganisms. 
The bacterial suspensions were cultured in the nutrient broth 
(Imuna, Slovakia) at 37 °C and the yeast suspension was cultured 
in the malt extract broth (Biomark, India) at 30 °C.
Antimicrobial assay
The minimum inhibitory concentration (MIC) is the lowest 
concentration of the sample that will inhibit the visible growth of 
microorganisms. Anchovy gut fractions dissolved in DMSD were 
prepared to a final concentration of 1024 μg/mL by dissolving 
stock solution with 102.4 mg/100 mL. MICs were determined 
by the microbroth dilution method according to the Clinical 
and Laboratory Standards Institute recommendation 2009 in 
Mueller Hinton broth (Biolife, Italy) for bacteria. Briefly, the 
DMSD anchovy gut fractions solutions were prepared as serial 
two-fold dilutions, in order to obtain a final concentration ranging 
between 0.5-512 μg/mL. Each well was then inoculated with 
microbial suspension at the final density of 0.5 McFarland. After 
24 h incubation of bacteria at 37 °C, the inhibition of microbial 
growth was evaluated by measuring the well absorbance at 
450 nm in an absorbance microplate reader Biotek EL808with 
shaker (Biotek Instruments, USA). The 96 micro-well plates were 
measured before and after experiment. Differences between both 
measurements were evaluated as growth. Measurement error 
was established for 0.05 values from absorbance. Wells without 
anchovy gut fractions were used as positive controls of growth. 
Pure DMSD was used as negative control. This experiment was 
done in eight-replicates for a higher accuracy of the MICs of 
used anchovy gut fractions.
2.7 Statistical analysis
Data were analyzed using analysis of variance (ANDVA) 
with Tukey-Kramer test (p < 0.05) with the aid of JMP statistical 
software (Visual statistical discovery, version software 5.01).
3 Results
3.1 Antimutagenic activity
The antimutagenic potential of fractions obtained from 
anchovy viscera was determined using Salmonella typhimurium 
TA100 tester strain and sodium azide as a control mutagen in 
order to test these fractions against a direct (does not requires 
bioactivation) mutagen. As shown in Table  1, all anchovy 
fractions were capable of inhibiting the mutagenicity induced by 
1.5 μg sodium azide / plate; however, only HF and EAF showed 
this antimutagenicity activity exhibiting a dose-response type 
of relationship. Similar results were observed when anchovy 
viscera fractions were tested against aflatoxin B1 (AFB1) 
(potent mutagen that requires bioactivation) and now using 
both, Salmonella typhimurium TA98 and 100 tester strains. In 
this assay (Table 2), HF and EAF could also partially inhibit 
the mutagenicity of 500 ng AFB1/plate. Even though they did 
not show a clear dose-response type of relationship as against 
sodium azide, HF kept the number of revertants/plate at the 
spontaneous reversion level, suggesting the presences of strong 
antimutagenic compounds in this fraction.
3.2 Antioxidant activity
Due to characteristics (yield and homogeneity), only HF, 
ALF, ACF, and BF were selected to antioxidant activity analyses. 
As shown in Table 3, the antioxidant activity by all three methods 
used (DPPH, ABTS, and FRAP) ranged from 130-2328 mmol 
Trolox / Kg. The highest values were achieved by ACF for DPPH 
and ABTS, and by BF when the FRAP method was used. Dn 
the other hand, the lowest values were obtained using the FRAP 
method, almost by one order of magnitude and for all fractions 
tested, being the lowest value observed for ALF.
3.3 Antifungal activity
Figure  1 shows results obtained in the radial growth 
inhibition assay, where Alternaria alternata was grown in PDA 
medium amended with 2 mg/mL anchovy viscera fractions HF 
Table 1. Anti-mutagenic potential of sodium azide§-spiked anchovy viscera 
fractions (average‡ Salmonella typhimurium TA100 revertants/plate).
Extract¶
Fraction concentration† (mg/plate)
5.0 0.5 0.05 0.005
TA98
HF 140 ± 20b 180 ± 11 a 212 ± 10 a 225 ± 35 a
EAF 83 ± 77 b 118 ± 33 ab 227 ± 35 a --
BF 207 ± 72 b 77 ± 51 b 192 ± 16 ab 212 ± 34 a
ALF 474 ± 32 a 201 ± 1 a 159 ± 15 b 163 ± 32 a
ACF 161 ± 20 b 172 ± 34 a 149 ± 10 b 176 ± 16 a
§Sodium azide (used as positive control) tested at 1.5 μg/plate induced 2613 ± 1712 
revertants/plate. Spontaneous revertants were 146 ± 20. ‡Values are means of three 
replicates ± standard deviation. †Extracts were diluted and spiked with enough sodium 
azide to yield 1.5 μg/plate. ¶HF=Hexanic Fraction, EAF=Ethyl Acetate Fraction, 
BF=Butanolic Fraction, ALF=Aqueous Liquid Fraction, and ACF=Aqueous Crystallized 
Fraction. Different letter within a column means statistical differences (p>0.05).
Table 2. Anti-mutagenic potential of aflatoxin B1 (AFB1) §-spiked 
anchovy viscera fractions (average‡ Salmonella typhimurium TA98 
and TA100 revertants/plate).
Extract¶
Fraction concentration† (mg/plate)
5.0 0.5 0.05 0.005
TA98
HF 43 ± 8c 453 ± 145a 331 ± 56a 400 ± 42a
EAF 200 ± 33c 693 ± 136a 491 ± 104a 400 ± 82a
BF 1579 ± 281a 712 ± 124a 637 ± 185a 292 ± 198a
ALF  903 ± 152 b 459 ± 18a 485 ± 134a 363 ± 33a
ACF 1585 ± 162 a 677 ± 46a 357 ± 33a 555 ± 68a
TA100
HF 114 ± 6d 1387 ± 66a 1163 ± 227a  880 ± 24ab
EAF 543 ± 61c 1376 ± 261a 792 ± 44a 1004 ± 99a
BF 2206 ± 109a 917 ± 39a 689 ± 73a 551 ± 113b
ALF 1676 ± 303b 1015 ± 306a 1019 ± 148a 1056 ± 157a
ACF 597 ± 66c 917 ± 129a 903 ± 39a 864 ± 114ab
§AFB1 (used as positive control) tested at 500 ng/plate induced 689 ± 75 and 
1211 ± 36 revertants/plate for TA98 and TA100, respectively. Spontaneous revertants 
were 35 ± 13 and 128 ± 20 for TA98 and TA100, respectively. ‡Values are means of three 
replicates ± standard deviation. †Extracts were diluted and spiked with enough mycotoxin 
to yield 500 ng of pure AFB1/plate. ¶HF=Hexanic Fraction, EAF=Ethyl Acetate Fraction, 
BF=Butanolic Fraction, ALF=Aqueous Liquid Fraction, and ACF=Aqueous Crystallized 
Fraction. Different letter within a column means statistical differences (p>0.05).
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and ALF. Both fractions were capable of exerting inhibition of 
fungus radial growth, being up to 26% inhibition exerted by 
HF compared to controls. These results suggest the presence of 
antifungal compounds in these fractions, whose activity might 
be increased, as they could be further isolated.
3.4 Antibacterial activity
Hexanic (HF) and butanolic (BF) were tested for their 
antibacterial activity against three Gram (+) and three Gram (-) 
bacterial species that are of importance for the food industry. 
As shown in Table 4, values for the Minimal Inhibitory Concentration 
50 (MIC50) and 90 (MIC90) were obtained for both anchovy 
viscera fractions against the six species tested. All these values 
ranged from 0.8-27.1 mg/100 mL. Lowest values (indicating 
the highest antibacterial activity) were observed for HF against 
Enterococcus feacalis, Bacillus subtilis, and Staphylococcus aureus. 
It is important to mention that these values are comparable to 
those reported for commercial antibiotics, an issue that will be 
further discussed.
4 Discussions
The viscera from several marine species have been studied 
as a source of biologically active compounds. Antimutagenic 
compounds have been detected and isolated from several 
marine animals such as fish species (Burgos-Hernandez et al., 
2002; Dh et al., 2008), crustaceans (Wilson-Sánchez et al., 2010; 
López-Saiz  et  al., 2014), and mollusks (Moreno-Félix  et  al., 
2013; Cruz-Ramírez et al., 2015); however, studies reported the 
presence of antimutagenic compounds from seafood viscera 
were not found. In the present study, antimutagenic fractions 
obtained from cantabrian anchovy viscera are for the first time 
reported. Moreover, antimutagenic anchovy viscera fraction 
HF was found to be capable of inhibiting the mutagenicity of 
two types of potent mutagens (sodium azide and AFB1) down 
to the spontaneous reversion level, which suggest the presence 
of highly antimutagenic lipid soluble compounds that might 
be of great interest for the biomedical industry as a potential 
chemopreventive agents.
The antimutagenic activity detected in anchovy viscera is 
consistent with the high antioxidant activity determined in fractions 
obtained from this source. Even though, antioxidant activity has 
been reported in masou salmon (Oncorhynchus masou) (Dh et al., 
2008), croaker (Otolithes ruber) (Nazeer et al., 2012), sardinelle 
(Sardinella aurita) (Bougatef et al., 2010), tilapia (Oreochromis 
niloticus) (Zhang et al., 2012); among other species, only one study 
was found where horse mackerel (Magalaspis cordyla) viscera 
extracts had antioxidant activity (Sampath-Kumar et al., 2011). 
In addition, is worth to mention that antioxidant activity values 
reached by BF (1354 mmol Trolox/Kg) and ACF (1522 mmol 
Trolox/Kgby the DPPH method, are similar to those reported 
in fruits such as apple (1200-1600 mmol Trolox/Kg) and 
tangerine (1500-2000 mmol Trolox/Kg) (Pyo et al., 2014). All of 
the above suggest that cantabrian anchovy viscera is a source 
of both, hydrophobic and hydrophilic antioxidant compounds 
whose activity could be even much higher once they could be 
completely isolated; based on the that, these compounds have 
a high potential for being employed in both, food preservation 
industry as well as in the pharmaceutical area.
A low antifungal activity was found in fractions obtained 
from anchovy viscera, since only 26% of fungal growth inhibition 
Table 3. Antioxidant activities of anchovy viscera fractions as assessed 
using the DPPH, ABTS, and FRAP methods.
Fraction DPPH(mmol Trolox/ Kg)
ABTS
(mmol Trolox/ Kg)
FRAP
(mmol Trolox/ Kg)
HF 964.8a ± 183.4 1368.4 ± 182.6 183.0 ± 56.14
BF 1354.1 ± 543.6 2002.4 ± 724.3 457.6 ± 410.3
ACF 1522.1 ± 330.5 2328.2 ± 513.6 280.7 ± 40.3
ALF 820.3 ± 438.4 1246.2 ± 691.0 130.6 ± 67.4
a Values are means from triplicates ± SD.
Figure 1. Radial growth of Alteraria alternata in the presence of anchovy 
viscera fractions. Potato Dextrose Agar (PDA) and PDA in the presence 
of methanol (C-methanol) were used as controls.
Table 4. Antibacterial activity of anchovy viscera fractions assessed on both, Gram (+) and Gram (-) species.
Target microrganism
Hexane fraction Butanol fraction
MIC50
(mg/100 mL)
MIC90
(mg/100 mL)
MIC50
(mg/100 mL)
MIC90
(mg/100 mL)
Salmonella enterica subs. enterica CCM 3807 6.39a 6.81 6.39 6.81
Shigella sonei CCM 1373 10.70 17.48 14.45 22.21
Escherichia coli CCM 3988 12.78 13.59 6.39 6.81
Staphylococcus aureus subs. aureus CCM 2461 3.19 3.41 25.52 27.13
Bacillus subtilis sub. spizizenii CCM 1999 2.13 2.38 25.52 27.13
Enterococcus faecalis CCM 4224 0.79 0.85 6.47 11.24
a Values are means from eight replicates.
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was achieved. Previous studies have reported antifungal 
peptides from sea lamprey (Petromyzon marinus) plasma (Rose 
& Durth, 2009) and protein compounds from mussel species 
Mytilus galloprovincialis (Sonthi et al., 2012) and Crenomytilus 
grayanus (Chikalovets et al., 2015). Based on this, the compounds 
responsible for the antifungal activity observed in the fractions 
from anchovy viscera, might be of protein or peptide nature, which 
possible were not appropriately extracted with the procedure 
used in the present study. Therefore, the use of an appropriate 
method to extract peptides from cantabrian anchovy viscera 
is recommended in order to more extensively investigate the 
antifungal potential of this source.
Dn the contrary to the low antifungal activity found in 
the anchovy fractions studied, a high antibacterial activity 
was observed in some of them. Antibacterial activity values 
observed (MIC50 of 0.79 mg HF/100 mL against Enterococcus 
faecalis CCM 4224) in these fractions are comparable to those 
that have been reported for commercial antibiotics such as 
vancomicin (MIC50 of 0.2 mg/100 mL against Staphylococcus 
endophthalmitis) (Harper et al., 2007). However, the antibacterial 
activity (one order of magnitude higher than vancomicin MIC50 
against Staphylococcus endophthalmitis) observed against the 
other species, as well as for the other bioactivities studied, could 
also increase with the isolation of the bioactive compounds. 
This suggests the presence of potent antimicrobial compounds 
that could be of great interest for the pharmaceutical industry.
5 Conclusions
Cantabrian anchovy waste such as viscera, contains 
antimutagenic, antioxidant, antifungal, and antibacterial 
compounds, which are mainly localized in the hexane-, 
butanol-, and methanol/water-soluble fractions. Even though 
it is recognized that the primary level of isolation impedes the 
bioactive compound to fully express their biological effects, the 
fact that this condition did not inhibit some antioxidant and 
antibacterial compounds to show very high levels of activity, 
suggests anchovy viscera as a promising source of bioactive 
compounds that are worthy of further research for biomedical, 
pharmaceutical, and food industries.
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